NEW YORK, Sept. 21 /PRNewswire/-- E.K.Guard, Inc., a privately held company that combines innovative medical technologies and services for solving today’s most difficult healthcare problems, today announced the formation of its new Medical Advisory Board. The Board is comprised of doctors recognized for their advanced knowledge in the field of cardiology and related specialties, as well as their contribution to furthering innovative technologies in the medical arena.
Allan Schwartz, MD, is the Chief of Cardiology and Seymour Milstein Professor of Clinical Medicine in the College of Physicians and Surgeons, Department of Medicine, Columbia University Medical Center, and will serve as Chairman of the Advisory Board. Dr. Schwartz, a world-renowned cardiologist, is also an Attending Physician at New York Presbyterian Hospital and Colombia University Medical Center.
Also on E.K.Guard’s Advisory Board are: * Joseph S. Alpert, MD: Head of Department of Medicine, University of Arizona Health Services Center; Editor in Chief, The American Journal of Medicine * Mark A. Apfelbaum, MD: Chief of Interventional Cardiologist Network, Columbia University Medical Center * Christopher P. Cannon, MD: Associate Professor Harvard, Senior Investigator TIMI Study Group, Associate Physician Brigham and Women’s Hospital * Martin B. Leon, MD: Chairman, Cardiovascular Research Foundation(R), Associate Director, Center for Interventional Vascular Therapy, Columbia University Medical Center
“E.K.Guard is pleased to welcome these outstanding experts to our Advisory Board,” said Jay R. Lichtenstein, President and CEO of E.K.Guard. “Their knowledge and experience will help guide E.K.Guard’s current and future medical developments as we continue to spearhead the advancement of new medical technologies and services that deliver life-saving and life-enhancing opportunities for patients.”
“E.K.Guard’s advanced technology and innovative service model will save lives by dramatically reducing time-to-treatment, a critical factor in cardiac care,” said Dr. Schwartz. “I am pleased to have the opportunity to work with some of the finest medical minds in the world to help develop this new standard of cardiac care.
“I expect that E.K.Guard will offer patients peace-of-mind if it’s not serious, and faster treatment to save their lives if it is a heart attack,” Dr. Schwartz continued. “It will also help doctors by extending their abilities to provide care -- which now can be obtained by patients at any time, day or night. Over the past decade, this type of service has repeatedly been proven in England, Germany, Switzerland, Israel and other countries. Now it’s available here in the tri-state area. I believe the eventual success of E.K.Guard will be measured by the many lives it will save.”
The E.K.Guard service combines a remote cardiac assessment with an emergency response mechanism. E.K.Guard member patients have access to a team of cardiologists and nurses, 24-hours a day, seven days a week. They are also equipped with a small, easy-to-use handheld personal electrocardiogram (EKG) device, approved by FDA, that records the same high-quality 12-Lead electrocardiogram doctors use in their offices and in hospitals.
The device is designed to transmit EKG results by telephone to the E.K.Guard Cardiologist Call Center. Call Center cardiologists will use this information to help determine if the patient is having a heart attack or if their cause for concern is really nothing to worry about. If it’s an emergency, E.K.Guard’s service will dispatch an ambulance, alert the E.R. and the patient’s regular doctor. If it’s a false alarm, the patient’s mind is put at ease, and since they found out from the comfort of their own home or wherever they might be, a costly, unnecessary trip to the E.R. is avoided. The whole process takes only five minutes.
About E.K.Guard
E.K.Guard, Inc. is a privately held company that combines innovative medical technologies and services to create a new standard of care for solving today’s most difficult healthcare problems. The company’s life-saving technologies and services quickly put patients and their vital medical information in immediate contact with remotely located doctors and other medical experts. The experts interact directly with the patient by phone while assessing the comprehensive information that’s been transmitted to them so they can advise the patient on appropriate care. For more information, please visit the E.K.Guard website at http://www.EKGuard.com.
E.K.Guard’s highly experienced management team, led by president and CEO Jay R. Lichtenstein, has a successful track record bringing a wide range of healthcare products and services to the market.
For more information visit www.EKGuard.com or contact: Kirsten Plonner Kelly Wester RF|Binder Partners RF|Binder Partners 212.994.7546 212.994.7586 kirsten.plonner@rfbinder.comkelly.wester@rfbinder.com
E.K.Guard, Inc.
CONTACT: Kirsten Plonner, RF|Binder Partners, +1-212-994-7546,kirsten.plonner@rfbinder.com, or, Kelly Wester, RF|Binder Partners, +1-212-994-7586, kelly.wester@rfbinder.com, both for E.K.Guard, Inc.
Web site: http://www.ekguard.com/
